Patent · US Active

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

US11104715B2 · kind B2 · utility

4Cited by
66References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 18, 2020
Grant dateAug 31, 2021
Priority date—
Expiry dateAug 18, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.